ClinicalTrials.Veeva

Menu

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

P

Power Life Sciences

Status

Not yet enrolling

Conditions

Pulmonary Fibrosis

Study type

Observational

Funder types

Industry

Identifiers

NCT05899556
83217345

Details and patient eligibility

About

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what research attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of pulmonary fibrosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary fibrosis patients.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is at least 18 years of age
  • Diagnosis of pulmonary fibrosis
  • Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.

Exclusion criteria

  • Enrolled in another research study
  • Inability to provide written informed consent
  • Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Michael B Gill

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems